Ben Venue extends plant shutdown

January 3, 2012
Manufacturing and Production Ben Venue

Troubled contract manufacturing organisation Ben Venue Laboratories has said it will have to extend its temporary shutdown of a facility …

Pharma manufacturing in brief

January 3, 2012
Manufacturing and Production IGI Laboratories, aseptic packaging

Pharma manufacturing news in briefCPL shuts down a facility in New Jersey, US, Tamer plans a new plant in Saudi …

AAIPharma expands in North Carolina

January 3, 2012
Manufacturing and Production AAIPharma

AAIPharma Services is planning to expand its contract analytics facility in Wilmington, North Carolina, with a new 40,000 sq. ft. …

p0024

Avastin gains EU licence for ovarian cancer

January 3, 2012
Sales and Marketing Roche, avastin, ovarian

Roche’s Avastin has been granted a new European licence to treat ovarian cancer, which could help offset falling sales of …

Introducing SHL’s first White Paper: “Auto Injectors: From Planning to Launch”

January 3, 2012
Manufacturing and Production auto injector, autoinjector, autoinjector manufacturing, autoinjector white paper, shl white paper

SHL is officially introducing the company’s first White Paper on the topic of “Auto Injectors; From Planning to Launch” with …

Working Life

January 1, 2012
Working Life

People working in pharma talking about what they like and dislike most about their jobs Mike Crooks, UK general manager, Astellas

Contract research news in brief

December 23, 2011
Manufacturing and Production AMRI, Frontage Labs, Kymos and Crystal3 Labs, Pacific Biomarkers/Cingene

A round up of news in the CRO sector, including cutbacks at AMRI and updates from Pacific Biomarkers/Clingene, Frontage Labs, …

NHS on track to make £358 million in drug savings

December 23, 2011
Sales and Marketing DoH, NHS, QIPP

The NHS in England is set to make £358 million in savings from drugs over the financial year, according to …

Ranbaxy picture

Ranbaxy sets aside $500m for manufacturing penalties

December 22, 2011
Manufacturing and Production

Indian drugmaker Ranbaxy Laboratories has set aside $500 million to pay financial penalties levied by the US FDA, resulting from …

RSA makes three new appointments

December 22, 2011
Business Services, Medical Communications, Sales and Marketing rsa

Life sciences recruitment firm RSA has announced three new appointments to its UK office. Dr David Jay joins RSA UK …

FDA accepts Pfizer’s arthritis pill for review

December 22, 2011
Research and Development, Sales and Marketing FDA, Pfizer, tofacitinib

The FDA has accepted Pfizer’s novel arthritis pill tofacitinib for review, and could be on the US market next year. …

GSK picture

GSK sells off over-the-counter brands

December 22, 2011
Sales and Marketing GSK, OTC

GlaxoSmithKline has offloaded a number of OTC consumer health brands in North America for £426 million in cash.  Flagged up …

Department of Health slims down agency partners

December 21, 2011
Medical Communications DH, Freud Communications, MEC

The Department of Health has stripped back its use of comms agencies in its public health campaigns by switching to …

AstraZeneca takes option on new diabetes candidates

December 21, 2011
Sales and Marketing AstraZeneca, diabetes

AstraZeneca and Prosidion, a subsidiary of Astellas have signed a deal giving AstraZeneca an exclusive option to acquire two diabetes …

andy_bowmanweb

Caudex Medical makes two senior appointments

December 21, 2011
Business Services, Medical Communications, Sales and Marketing Andy Bowman, Caudex Medical, Gary Burd

Andy Bowman and Gary Burd have been appointed to senior positions within the medical communications firm Caudex Medical.  Bowman has …

FDA picture

FDA to probe Gilenya patient death

December 21, 2011
Sales and Marketing FDA, Novartis, gilenya

The FDA is investigating Novartis’s new multiple sclerosis treatment Gilenya after a patient died within hours of taking the drug. …

Lilly teams up with ImmunoGen on antibody-drug conjugates

December 21, 2011
ADC, Cancer, Immunogen, T-DM1, conjugate, lilly, oncology

ImmunoGen has signed a new collaboration with Eli Lilly to develop antibody-drug conjugate for cancer treatments.Lilly will pay an upfront …

Xarelto gains new licences in UK

December 20, 2011
Sales and Marketing

Bayer’s anticoagulant pill Xarelto has gained two new lucrative licences, and is now available in the UK to prevent stroke …

AstraZeneca, Novo and Enlight sign collaborative research deal

December 20, 2011
Research and Development, Sales and Marketing AstraZeneca, Enlight, Novo Nordisk

AstraZeneca and Novo Nordisk have linked up with a US biosciences firm in a bid to enhance their R&D operations. …

Pharma manufacturing news in brief

December 20, 2011
Manufacturing and Production ADC Biotechnology, BioMarin, GE Healthcare, Lonza and Neptune Technologies, M+W Group

Facility news from BioMarin, Lonza and Neptune Technologies, plus plans to boost biomanufacturing capacity in the developing world and new …

The Gateway to Local Adoption Series

Latest content